Valaciclovir to Prevent Transmission of Herpes Simplex Virus

NCT00001649 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

180

Enrollment

NIH

Sponsor class

Conditions

Herpes Simplex

Interventions

DRUG: Valaciclovir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)